<?xml version="1.0"?>
<Articles JournalTitle="Basic &amp; Clinical Cancer Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Basic &amp; Clinical Cancer Research</JournalTitle>
      <Issn>2228-6527</Issn>
      <Volume>14</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>06</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Survival of GEJ and gastric adenocarcinoma patients admitted at Imam Khomeini and Aram oncology clinic and treated with preoperative EOX chemotherapy</title>
    <FirstPage>78</FirstPage>
    <LastPage>86</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Farahat</LastName>
        <affiliation locale="en_US">Yazd University of medical science</affiliation>
      </Author>
      <Author>
        <FirstName>Amirhossein</FirstName>
        <LastName>Emami</LastName>
        <affiliation locale="en_US">Department of Hematology and Oncology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Reza</FirstName>
        <LastName>Safaei Nodehi</LastName>
        <affiliation locale="en_US">Department of Hematology and Oncology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kamran</FirstName>
        <LastName>Roudini</LastName>
        <affiliation locale="en_US">Department of Hematology and Oncology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Shahi</LastName>
        <affiliation locale="en_US">Department of Hematology and Oncology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>01</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>01</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Abstract
&#xD;

Objective: We aimed to investigate safety and efficacy of preoperative chemotherapy using EOX regime in patients with locally advanced gastric and GEJ cancer who were admitted at Imam-Khomeini Oncology clinic and Aram clinic. 
&#xD;

Method: We performed a mix-cohort study in 51 gastric cancer patients. In the beginning, we performed contrast thorax and abdominal CT scan or ECO cardiograph to determine cancer staging. After that, each patient received 3-weeks EOX regime in 6 cycle. After each three cycles follow-up CT scan was performed to assess any possible progression. Response to the treatment, Overall survival, and Progression-Free Survival were the main outcomes that we evaluated in the current study. We used Kaplan-Meier approach and Cox regression to address survival rate and its prognostic factors.
&#xD;

Results: Overall, 72.5% percent were male and mean age of study participants was 57.6. Complete response rate was observed in 11.1%, while 51.1% showed partial response. Median of overall survival and Progression-Free Survival was estimated 35.0 and 28.0 month, respectively. The 5-year overall survival was 74.2% and for PFS it was estimated at 57.7%.
&#xD;

Conclusion: Preoperative chemotherapy using EOX regime could increase survival rate among patients with gastric and GEJ cancer.</abstract>
    <web_url>https://bccr.tums.ac.ir/index.php/bccrj/article/view/414</web_url>
  </Article>
</Articles>
